Verily Layoffs

About

Verily, Alphabet's life sciences unit, laid off approximately 35 to 40 employees this week as part of a restructuring within its molecular sciences group. The affected staff were working on the Immune Profiler project, which focuses on studying the human immune system to improve disease management. This move is part of an ongoing cost-cutting drive, following a larger layoff of over 200 employees (15% of its workforce) in January 2023. The company, which operates in the health tech and life sciences industry as one of Alphabet's "Other Bets," is striving to become a profitable business and is currently undergoing a separation from Alphabet's infrastructure, with a deadline set for the end of 2024.

Source

Related Events

More Healthcare Layoffs